Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass., Jan. 02, 2024 Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high.
CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas
Japan OKs 1st domestic-made COVID shots tailored for Omicron subvariant japantoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantoday.com Daily Mail and Mail on Sunday newspapers.